Life Science Company News

Results 41 - 60 out of 500 displayed.
«  1  2 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Tizona Therapeutics Presents Phase 1b TTX-080 Clinical Data in Advanced Colorectal Cancer and Head and Neck Squamous Cell Carcinoma at ASCO 2024

Read more ››
By: GlobeNewswire - 23 May 2024

Kymera Therapeutics to Present New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at ASCO Annual Meeting

Read more ››
By: GlobeNewswire - 23 May 2024

Genmab to Showcase Data in Various Patient Populations to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting

Read more ››
By: GlobeNewswire - 23 May 2024

Evaxion to Present New Positive Data from Ongoing Phase 2 Study on Lead Vaccine Candidate EVX-01 at the American Society of Clinical Oncology Annual Meeting 2024

Read more ››
By: GlobeNewswire - 23 May 2024

Replimune to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Read more ››
By: GlobeNewswire - 23 May 2024

Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual Meeting

Read more ››
By: GlobeNewswire - 23 May 2024

Theratechnologies’ Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors

Read more ››
By: GlobeNewswire - 23 May 2024

Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual Meeting

Read more ››
By: GlobeNewswire - 23 May 2024

Candel Therapeutics Reports Prolonged Overall Survival in Phase 2 Clinical Trial of CAN-2409 for Advanced Non-Small Cell Lung Cancer (NSCLC) in Patients Non-Responsive to Immune Checkpoint Inhibitor (ICI) Treatment at 2024 ASCO Annual Meeting

Read more ››
By: GlobeNewswire - 23 May 2024

Werewolf Therapeutics to Present Updated Data from Phase 1/1b Clinical Trial of WTX-124 as Monotherapy and in Combination with Pembrolizumab in Solid Tumors at 2024 ASCO Annual Meeting

Read more ››
By: GlobeNewswire - 23 May 2024

IN8bio Announces INB-200 Phase 1 Study Data in Newly Diagnosed Glioblastoma to be Presented at the 2024 ASCO Annual Meeting

Read more ››
By: GlobeNewswire - 23 May 2024

Arvinas Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Congress

Read more ››
By: GlobeNewswire - 23 May 2024

Cogent Biosciences Announces Positive Updated Lead-In Data from Ongoing Phase 3 PEAK Trial Evaluating Bezuclastinib in Combination with Sunitinib in Patients with Gastrointestinal Stromal Tumors (GIST) at ASCO Annual Meeting

Read more ››
By: GlobeNewswire - 23 May 2024

HOOKIPA Pharma Announces Positive Clinical Data to be Presented at the American Society for Clinical Oncology 2024 Annual Meeting

Read more ››
By: GlobeNewswire - 23 May 2024

Zentalis Pharmaceuticals to Present Promising Results from Phase 1 Trial of Azenosertib and Gemcitabine in Relapsed or Refractory Osteosarcoma at 2024 American Society of Clinical Oncology Annual Meeting

Read more ››
By: GlobeNewswire - 23 May 2024

Promising Anti-tumor Activity of Novel Costimulatory Bispecific Antibody REGN7075 (EGFRxCD28) in Combination with Libtayo® (cemiplimab) to be Reported at ASCO

Read more ››
By: GlobeNewswire - 23 May 2024

Cullinan Therapeutics to Present First Data for CLN-619, a Novel Anti-MICA/B Antibody, in Combination with a Checkpoint Inhibitor and Updated Monotherapy Data at ASCO 2024

Read more ››
By: GlobeNewswire - 23 May 2024

BioAtla Presenting Phase 1 Evalstotug Clinical Trial Data Demonstrating Clinical Benefit at the Upcoming 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Read more ››
By: GlobeNewswire - 23 May 2024

I-Mab Announces Encouraging Phase 1 Clinical Data of PD-L1x4-1BB Bispecific Antibody Ragistomig at ASCO 2024

Read more ››
By: GlobeNewswire - 23 May 2024

Compass Therapeutics to Present Phase 1 Data for CTX-471, A Novel CD137 Agonist Antibody, Demonstrating Anti-Tumor Activity in Patients Who Have Progressed on Approved PD-1 or PD-L1 Inhibitors at the American Society of Clinical Oncology (ASCO) Annua

Read more ››
By: GlobeNewswire - 23 May 2024
Results 41 - 60 out of 500 displayed.
«  1  2 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate